Skip to main content
Clinical Trials/NL-OMON49937
NL-OMON49937
Not yet recruiting
Not Applicable

The role of the gut microbiome in the pathogenesis of IgA nephropathy - The role of the gut microbiome in the pathogenesis of IgA nephropathy

Radboud Universitair Medisch Centrum0 sites150 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
150
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Biopsy\-proven
  • eGFR 15 \- 90 ml/min/1\.73m2
  • Age 18 \- 70 years

Exclusion Criteria

  • No informed consent
  • Secondary causes of glomerular IgA depositions:
  • \- Liver disease; cirrhosis, hepatitis B
  • \- Gastro\-intestinal disease; inflammatory bowel disease (IBD), celiac disease,
  • major gastro\-intestinal surgery
  • \- Skin disease; dermatitis herpetiformis, psoriasis
  • \- Pulmonary disease
  • \- Malignant disease
  • \- Current infection
  • \- IgA monoclonal gammopathy

Outcomes

Primary Outcomes

Not specified

Similar Trials